#1 Clinical Trials Search in Europe

Remimazolam

Remimazolam is a novel sedative drug being studied in clinical trials for use in various medical procedures. This article summarizes key findings from recent trials evaluating remimazolam’s safety and effectiveness compared to other sedatives, particularly for endoscopic procedures and anesthesia induction in both adults and children.

Table of Contents

What is Remimazolam?

Remimazolam is a new medication that belongs to a class of drugs called benzodiazepines. It is also known by its research names CNS 7056 and ONO-2745[1]. Remimazolam is considered an ultra-short-acting benzodiazepine, which means it works quickly and its effects don’t last long in the body[2].

Uses of Remimazolam

Remimazolam is primarily used for:

  • Procedural sedation: This means making patients calm and sleepy during medical procedures. It has been studied for use in colonoscopies (a procedure to examine the large intestine) and upper GI endoscopies (a procedure to examine the upper part of the digestive system)[1][3].
  • General anesthesia: This is a state of controlled unconsciousness that allows patients to undergo surgery without pain or awareness[4].
  • Sedation in intensive care units (ICUs): It has been studied for use in patients with severe breathing problems, including those with COVID-19[5].

How Remimazolam Works

Remimazolam works by enhancing the effects of a natural chemical in the brain called GABA. This leads to sedation (sleepiness and calmness), reduced anxiety, and muscle relaxation. Because it’s ultra-short-acting, its effects wear off quickly once the medication is stopped[2].

Administration and Dosage

Remimazolam is given intravenously (through a vein). The dose can vary depending on the purpose:

  • For colonoscopies, doses ranging from 5 mg to 8 mg have been studied[1].
  • For general anesthesia, it may be given as a continuous infusion, with rates of 0.5-2 mg/kg/hour studied[4].
  • In ICU settings, doses of 0.2-1 mg/minute have been used[5].

The exact dose is determined by the doctor based on the patient’s needs and response.

Effectiveness

Studies have shown that remimazolam can effectively sedate patients for procedures. Its effectiveness is often measured by:

  • Success of the procedure: This includes achieving the right level of sedation, completing the procedure, and not needing additional sedative medications[1].
  • Time to fully alert: How quickly patients wake up and become fully conscious after the procedure[3].
  • Time to ready for discharge: How soon patients are ready to go home after the procedure[3].

Safety and Side Effects

Like all medications, remimazolam can have side effects. Researchers closely monitor:

  • Cardiovascular effects: Changes in blood pressure and heart rate[5].
  • Respiratory effects: Changes in breathing rate or oxygen levels[5].
  • Emergence agitation: Confusion or agitation when waking up from sedation[4].
  • Pain at the injection site[6].

In general, because remimazolam is short-acting, many of its effects wear off quickly once the medication is stopped.

Special Populations

Researchers are studying how remimazolam affects different groups of people:

  • Patients with liver problems: Studies are looking at how liver disease affects the way the body processes remimazolam[6].
  • Children: Research is ongoing to determine safe and effective doses for pediatric patients[7][8].
  • Patients with heart disease: Studies are examining its use in patients undergoing heart surgery[2].

Ongoing Research

Remimazolam is still being studied to better understand its uses and effects. Current research includes:

  • Comparing it to other sedatives like propofol and midazolam[4][1].
  • Studying its use in combination with other medications like fentanyl (a pain medication)[7].
  • Investigating its use in emergency situations, such as during the COVID-19 pandemic when there were shortages of other sedatives[5].

As research continues, we’ll learn more about the best ways to use remimazolam to help patients during medical procedures and in intensive care settings.

Aspect Details
Drug Name Remimazolam (also known as CNS 7056)
Drug Class Benzodiazepine
Main Uses Studied Procedural sedation (e.g., colonoscopy, upper GI endoscopy), anesthesia induction
Age Groups Adults and children (pediatric studies ongoing)
Comparison Drugs Primarily midazolam
Key Potential Benefits Faster onset and recovery, more predictable effects
Safety Monitoring Vital signs, adverse events, cognitive function, pain on injection
Special Populations Studied Patients with hepatic impairment, COVID-19 patients in ICU
Administration Intravenous injection or infusion
Current Status Multiple Phase II and III trials completed or ongoing

FAQ

  • What is remimazolam? Remimazolam is a new sedative medication being studied for use in medical procedures. It belongs to the benzodiazepine class of drugs but has a shorter duration of action compared to older medications like midazolam.
  • What types of procedures is remimazolam being tested for? Clinical trials are evaluating remimazolam for use in procedures like colonoscopy, upper GI endoscopy, and general anesthesia induction in both adults and children.
  • How does remimazolam compare to other sedatives? Studies are comparing remimazolam to medications like midazolam. Early results suggest remimazolam may provide adequate sedation with potentially faster recovery times, but more research is needed.
  • What are the potential benefits of remimazolam? Potential benefits being studied include faster onset of sedation, more predictable effects, and quicker recovery times compared to other sedatives. However, these need to be confirmed in larger trials.
  • Are there any safety concerns with remimazolam? As with any sedative, researchers are closely monitoring for side effects like changes in blood pressure, heart rate, and breathing. So far, the safety profile appears similar to other benzodiazepines, but more data is needed.

Ongoing Clinical Trials on Remimazolam

  • A Study Comparing Remimazolam and Midazolam for Sedation in Adults During Upper Gastrointestinal Endoscopy

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Comparing Remimazolam and Propofol for Deep Sedation in Patients Undergoing Endoscopic Ultrasound for Gastric and Pancreatic Cancer

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of Fast Awakening from General Anesthesia Using a Drug Combination Including Remimazolam in Healthy Volunteers

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Testing the effectiveness and safety of remimazolam, ketamine, and propofol for rapid sequence induction in patients at risk of aspiration

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

  • Title: Evaluation of nasal remimazolam and lidocaine for sedation and anxiety in adults: Testing comfort and effectiveness of nasal spray delivery

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Sedation for Colonoscopy: Comparing Remimazolam with Fentanyl and Midazolam with Fentanyl in Screening Patients

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

Glossary

  • Remimazolam: A new sedative medication belonging to the benzodiazepine class, being studied for use in medical procedures. It has a shorter duration of action compared to older benzodiazepines.
  • Sedation: A state of calm or sleep induced by medication to help patients relax during medical procedures.
  • Endoscopy: A medical procedure where a long, thin tube with a camera is inserted into the body to examine internal organs or tissues.
  • Colonoscopy: A type of endoscopy procedure to examine the large intestine (colon) using a flexible tube with a camera.
  • Anesthesia induction: The process of administering medications to cause a patient to enter a state of unconsciousness before a medical procedure or surgery.
  • Midazolam: An older benzodiazepine medication commonly used for sedation in medical procedures, often used as a comparison drug in remimazolam studies.
  • Fentanyl: A strong opioid pain medication sometimes used in combination with sedatives during medical procedures.
  • Intravenous (IV): Administration of medication directly into a vein using a needle or tube.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and elimination.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT01145222
  2. https://clinicaltrials.gov/study/NCT05423951
  3. https://clinicaltrials.gov/study/NCT00869440
  4. https://clinicaltrials.gov/study/NCT05435911
  5. https://clinicaltrials.gov/study/NCT04611425
  6. https://clinicaltrials.gov/study/NCT01790607
  7. https://clinicaltrials.gov/study/NCT06170918
  8. https://clinicaltrials.gov/study/NCT05990673